MeiraGTx Holdings Plc (MGTX)
10.69
+0.19
(+1.81%)
USD |
NASDAQ |
Oct 09, 16:00
10.90
+0.21
(+1.96%)
After-Hours: 20:00
MeiraGTx Holdings Free Cash Flow (Quarterly) : -38.87M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -38.87M |
| March 31, 2026 | 15.80M |
| December 31, 2025 | 45.95M |
| September 30, 2025 | -12.82M |
| June 30, 2025 | -45.18M |
| March 31, 2025 | -38.54M |
| December 31, 2024 | -24.49M |
| September 30, 2024 | -25.75M |
| June 30, 2024 | -20.78M |
| March 31, 2024 | -38.42M |
| December 31, 2023 | -17.58M |
| September 30, 2023 | -27.98M |
| June 30, 2023 | -33.99M |
| March 31, 2023 | -46.00M |
| September 30, 2022 | -30.74M |
| June 30, 2022 | -41.81M |
| March 31, 2022 | -20.76M |
| December 31, 2021 | -5.541M |
| Date | Value |
|---|---|
| September 30, 2021 | -29.09M |
| June 30, 2021 | -26.84M |
| March 31, 2021 | -4.282M |
| December 31, 2020 | -39.80M |
| September 30, 2020 | -28.98M |
| June 30, 2020 | -15.80M |
| March 31, 2020 | -16.42M |
| December 31, 2019 | -26.72M |
| September 30, 2019 | -20.43M |
| June 30, 2019 | -22.84M |
| March 31, 2019 | 81.05M |
| December 31, 2018 | -20.35M |
| September 30, 2018 | -12.05M |
| June 30, 2018 | -19.14M |
| March 31, 2018 | -18.61M |
| September 30, 2017 | -7.380M |
| June 30, 2017 | -7.222M |
| March 31, 2017 | -8.133M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Xencor, Inc. | -56.20M |
| UroGen Pharma Ltd. | -35.08M |
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Viking Therapeutics, Inc. | -125.17M |
| IDEAYA Biosciences, Inc. | -89.08M |